Status | Study |
Completed |
Study Name: A Phase I, Safety Study of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Children Condition: The Study Focused on the Safety of Attenuated Mumps Vaccine (Human Diploid Cell) Against Mumps in Chinese Adults, Children and Infants. Date: 2012-10-22 Interventions: Biological: 3.50±0.25logCCID50/ml |
Completed |
Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life Condition: Measles Mumps Rubella Date: 2012-09-06 Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209 |
Completed |
Study Name: Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age Condition: Rubella Mumps Measles Date: 2012-06-14 Interventions: Biological: Priorix® Sing |
Completed |
Study Name: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) Condition: Measles Mumps Rubella Date: 2012-02-16 Interventions: Biological: MMRV (AMP) Measles |
Completed |
Study Name: Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.) Condition: Mumps Date: 2011-07-07 Interventions: Drug: Botulinum Toxin Type A Botulinum Toxin Type A |
Completed |
Study Name: Making Decisions About the Measles-Mumps-Rubella Vaccine Condition: Measles Mumps Rubella Date: 2011-06-07 Interventions: Other: Behavioral: Computer-based tailoring system Both the intervention and control groups will use a c |
Completed |
Study Name: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers Condition: Japanese Encephalitis Measles Mumps Date: 2010-08-24 Interventions: Biological: Japanese encephalitis chimeric virus: Measles, mumps, and rubell |
Completed |
Study Name: Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136 Condition: Measles Varicella Mumps Date: 2008-09-10 Interventions: Biological: PriorixTM Subcutan |
Completed |
Study Name: Measles, Mumps, and Rubella (MMR) Immunity in College Students Condition: Measles Mumps Rubella Date: 2008-05-19 Interventions: Biological: MMR vaccine People with no antibodies to either mumps, measles and rubella will be offered t |
Completed |
Study Name: Immunogenicity, Safety of Measles-mumps-rubella-varicella Vaccine (MeMuRu-OKA) Compared to Priorix™ Given With Varilrix™ Condition: Mumps Rubella Measles Date: 2006-07-14 Interventions: Biological: MeMuRu-OKA (study vac) Biologi |